Dermata Therapeutics, Inc.DRMA
DRMA on Nasdaq: pharmaceutical preparations.
Listed on Nasdaq, Dermata Therapeutics, Inc. (DRMA) sits within the healthcare sector operating in pharmaceutical preparations.
A descriptive overview for DRMA is pending the next reference-data sync.
What the trading floor has done with DRMA.
Below is the outcome history for DRMA from Sensei's alert feed. Entry, target, and stop levels — plus the chart-level reasoning — are members-only.
- BUYMar 27, 2025Hit+8.22%
- BUYSep 16, 2024No Fill
- BUYJul 24, 2024Hit+36.24%
- BUYJul 24, 2024Hit+7.37%
- BUYJul 24, 2024Hit+17.17%
- BUYJul 24, 2024Hit+46.87%
- BUYMay 12, 2023Hit+5.14%
- BUYMay 12, 2023Hit+9.85%
- BUYMay 12, 2023Hit+22.67%
- BUYMay 12, 2023Hit+13.23%
Full details unlock inside the app
Common questions about this stock.
What is DRMA?
DRMA is the trading symbol for Dermata Therapeutics, Inc., listed on Nasdaq in the healthcare sector.
What sector is DRMA in?
Dermata Therapeutics, Inc. (DRMA) is classified in the healthcare sector — specifically pharmaceutical preparations, based on its SEC SIC classification.
Has Sensei traded DRMA?
Yes — DRMA has appeared in the Sensei alert feed 10 times, including 9 calls that hit target. The "Sensei's calls on DRMA" section above lists the recent history; entry, target, and stop levels are members-only.
Where does DRMA trade?
DRMA trades on Nasdaq.
Is DRMA a stock or an ETF?
DRMA is a publicly-traded common stock, not an ETF.
Trade DRMA alongside Sensei.
Live alerts, a focused community, and the full course library. $60/month. Cancel anytime.